HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 296 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,016 | -99.6% | 56 | -99.6% | 0.00% | -100.0% |
| Q2 2023 | $1,133,128 | -12.9% | 13,309 | -15.3% | 0.00% | -33.3% |
| Q1 2023 | $1,300,499 | -58.3% | 15,716 | -60.3% | 0.01% | -64.7% |
| Q4 2022 | $3,115,562 | +72.9% | 39,613 | +62.8% | 0.02% | +54.5% |
| Q3 2022 | $1,802,000 | +16.8% | 24,335 | +2.8% | 0.01% | 0.0% |
| Q2 2022 | $1,543,000 | -46.2% | 23,670 | -8.4% | 0.01% | -75.6% |
| Q1 2021 | $2,867,000 | -9.1% | 25,827 | -26.7% | 0.04% | -2.2% |
| Q2 2020 | $3,155,000 | +1302.2% | 35,224 | +1702.7% | 0.05% | +557.1% |
| Q4 2019 | $225,000 | -12.5% | 1,954 | -8.5% | 0.01% | -88.5% |
| Q2 2019 | $257,000 | +29.1% | 2,135 | +23.1% | 0.06% | +134.6% |
| Q3 2018 | $199,000 | +397.5% | 1,735 | +293.4% | 0.03% | +4.0% |
| Q2 2018 | $40,000 | – | 441 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |